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Abstract
Introduction: A disturbed regulation mechanism of arginine vasopressin secretion in response to plasma osmolality and volaemia changes 
occurs in hypothyroidism. The aim of this study was to determine plasma arginine vasopressin concentration in hypothyroid women 
under conditions of a low sodium diet and in an upright position.
Material and methods: Twenty-six women with primary hypothyroidism and 24 healthy women (control group) were investigated. In all 
the patients, the plasma arginine vasopressin and serum sodium and potassium levels, as well as plasma osmolality, were measured first 
under basal conditions, i.e. after three days of a normal sodium diet (120 mmol sodium per day) in a horizontal position, and next after 
three days of a low sodium diet (10 mmol Na per day) in an upright position. In hypothyroid patients, the investigations were repeated 
after a euthyroid state as a result of L-thyroxine treatment had been attained.
Results: An increase of vasopressinaemia, measured under basal conditions as well as after three days of the low sodium diet, was shown 
in untreated hypothyroid patients compared to the control group. The arginine vasopressin plasma level normalised after a euthyroid 
state had been attained. As a result of the low sodium diet and the upright position, a significant increase of arginine vasopressin secretion 
was observed in the control group and hypothyroid women in the euthyroid state. No significant increase of this neuropeptide level in 
untreated patients was shown while applying the low sodium diet and upright position. Plasma osmolality and natraemia were decreased 
in the untreated hypothyroid patients. No correlation between vasopressinaemia and plasma osmolality was shown.
Conclusion: The plasma arginine vasopressin level is increased in hypothyroid women, and does not change in the upright position under 
the influence of a low sodium diet. (Pol J Endocrinol 2012; 63 (1): 18–21)
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Streszczenie
Wstęp: W niedoczynności tarczycy stwierdzono zaburzenia mechanizmu regulacji uwalniania argininowazopresyny w odpowiedzi na 
zmiany wolemii i osmolalności osocza. Celem pracy było określenie stężenia argininowazopresyny w osoczu kobiet chorych na niedoczynność 
tarczycy w warunkach diety ubogosodowej wraz z pionizacją.
Materiał i metody: Badania przeprowadzono u 26 kobiet z pierwotną niedoczynnością tarczycy i 24 kobiet zdrowych (grupa kontrolna). 
U wszystkich badanych kobiet określono stężenie argininowazopresyny w osoczu, sodu i potasu w surowicy krwi oraz osmolalność osocza, 
najpierw w warunkach podstawowych, czyli po 3-dniowej diecie normosodowej, zawierającej 120 mmol sodu na dobę, w pozycji leżącej, 
a następnie po 3-dniowej diecie ubogosodowej (10 mmol Na/dobę) i pionizacji. U chorych na niedoczynność tarczycy badania powtórzono 
w okresie eutyreozy po leczeniu L-tyroksyną. 
Wyniki: W porównaniu do grupy kontrolnej u nieleczonych chorych z niedoczynnością tarczycy wykazano zwiększenie wazopresynemii 
badanej w warunkach podstawowych i w warunkach diety ubogosodowej wraz z pionizacją. Stężenie hormonu w osoczu uległo normalizacji 
w okresie eutyreozy po leczeniu substytucyjnym. W następstwie stosowania diety ubogosodowej wraz z pionizacją obserwowano istotne 
pobudzenie wydzielania argininowazopresyny u kobiet z grupy kontrolnej i leczonych chorych z niedoczynnością tarczycy w okresie 
eutyreozy. U nieleczonych chorych nie wykazano istotnego wzrostu stężenia tego neuropeptydu, kiedy stosowano dietę ubogosodową 
wraz z pionizacją. U nieleczonych chorych na niedoczynność tarczycy osmolalność osocza i natremia były obniżone. W badaniach kore-
lacyjnych nie stwierdzono współzmienności pomiędzy wazopresynemią a osmolalnością osocza.
Wniosek: U kobiet chorych na niedoczynność tarczycy stężenie argininowazopresyny w osoczu jest zwiększone i nie zmienia się pod 
wpływem diety ubogosodowej wraz z pionizacją. (Endokrynol Pol 2012; 63 (1): 18–21)
Słowa kluczowe: niedoczynność tarczycy, argininowazopresyna, dieta ubogosodowa
Introduction
Disturbances in salt and water metabolism occur in hy-
pothyroidism, mainly as impaired free water excretion 
through the kidneys accompanied by hyponatraemia 
[1]. In the mechanism of this phenomenon, several 
factors are taken into consideration, among them the 
direct effect of thyroid hormones deficiency in the 
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sodium-potassium ATP-ase activity attenuation in the 
proximal renal tubules with a decrease of sodium reab-
sorption [2] and arginine vasopressin (AVP) influence 
(through aquaporin 2) on water reabsorption in the 
renal tubules in the medulla [3]. 
Hypothyroidism frequently leads to plasma AVP 
level changes. Previous studies have found ambigu-
ous results: in some, a vasopressinaemia decrease has 
been shown in hypothyroidism [4–6], while others have 
shown an increase both in people [7–9] and animals 
[3]. A few studies have shown that the AVP level in 
hypothyroidism has been the same as in healthy people 
[10, 11]. The syndrome of inappropriate AVP secretion 
in hypothyroidism has also been described [12–14]. 
Disturbed AVP secretion in response to plasma osmolal-
ity and volaemia changes is suggested in hypothyroid 
patients [5, 7, 9, 11, 15] and experimental animals [4]. 
Acute water loading has not led to the suppression of 
AVP secretion [9, 11, 15]. Other studies have shown 
the attenuation of the influence of increased plasma 
osmolality on this neurohormone secretion [5]. Sig-
nificantly higher vasopressinaemia has been observed 
in animals with experimental hypothyroidism in spite 
of the lower plasma osmolality [3]. The mechanisms 
regulating vasopressinaemia in hypothyroidism have 
not yet been fully explained.
The aim of this study was to establish the plasma 
AVP level in women with hypothyroidism taking into 
consideration the upright position and a differentiated 
diet with low and normal sodium content.
Material and methods
Twenty-six women with primary hypothyroidism, aged 
37.1 ± 8.4 (mean ± SD) years, were investigated. The hy-
pothyroidism had been caused by autoimmune thyroid 
inflammation in 20 women, and by surgical treatment 
in the other six. It was established that the duration of 
hypothyroidism symptoms had lasted for 1–50 (mean 
15.5) months. The disease was diagnosed on the basis of 
the clinical picture and TSH, serum free T4 and free T3 
concentration measurements. The investigations were 
repeated after the establishment of a euthyroid state 
resulting from a mean seven months (range 4–9 months) 
of substitutional L-thyroxine (Merck Euthyrox N) treat-
ment with a mean daily dose of 155 ± 50 µg. Twenty-four 
healthy women aged 35.4 ± 7.2 years were designated 
the control group (C). The patients were hospitalised. 
The study was approved by the Local Ethics Committee 
of the Medical University of Silesia. In all the patients, 
the plasma AVP and serum sodium and potassium 
levels, as well as plasma osmolality, were measured 
first under basal conditions, i.e. after three days of 
a normal sodium diet containing 120 mmol sodium 
and 70 mmol potassium per day in a horizontal posi-
tion after an eight-hour sleep. Next, the investigations 
were undertaken after three days of a low sodium diet 
(10 mmol Na and 70 mmol K per day) and two hours 
in the upright position (lsdp).
Blood samples were taken in a fasting state at about 
8 am from the ulnar vein. The blood samples with EDTA 
were immediately whirled in a centrifuge cooled to 4°C. 
The plasma was stored in a refrigerator at –30°C before 
measurements were taken.
The AVP plasma level was measured with a radioim-
mune method using the kit obtained from the Institute 
for Research, Productions and Applications of Radio-
isotopes, Prague, Czech Republic. Plasma osmolality was 
calculated according to the following formula: plasma 
osmolality [mosm/kg H2O] = 2 × sodium concentra-
tion (mmol/l) + glucose concentration [mmol/l]) + urea 
concentration [mmol/l] [5]. Heart rate and blood pressure 
were measured in the morning after a 20 minute rest in 
the sitting position in hypothyroid patients before treat-
ment, and again after achieving euthyreosis, as well as in 
the C group. Mean heart rate and blood pressure were 
calculated on the basis of three consecutive measurements 
in all cases. Body Mass Index (BMI) was also determined.
The obtained results were analysed using Statistica soft-
ware. It was assessed with the Shapiro–Wilk test whether the 
analysed parameter featured a distribution deviating from or 
close to normal. Next, t-Student tests for paired and unpaired 
variables were applied for data from a normal distribution 
and U-Mann–Whitney and Wilcoxon tests for data not fol-
lowing the normal distribution. The correlation coefficients 
‘r’ were calculated in the correlation studies with the Pearson 
or Spearman rank tests. The statistical significance of the dif-
ferences was established at the p < 0.05 level.
Results
The characteristics of the investigated patients, includ-
ing the serum TSH and free thyroid hormones levels, 
as well as BMI, systolic and diastolic blood pressure and 
heart rate, are presented in Table I. 
In hypothyroid patients before treatment and after 
achieving euthyreosis, the systolic and diastolic blood 
pressures were higher than in the C group. In comparison 
with the C group, an increase of vasopressinaemia meas-
ured under basal conditions (p < 0.001) and after lsdp 
(p < 0.01) was shown in untreated patients (Table II). The 
plasma level of AVP returned to normal in euthyreosis 
as a result of substitutional L-thyroxine treatment. AVP 
significant secretion stimulation after lsdp was observed 
in healthy individuals (p < 0.05) and treated hypothy-
roid patients during euthyreosis (p < 0.01) (Table II). In 
the untreated patients after lsdp, no significant increase 
of this neuropeptide concentration was shown. Plasma 
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Table I. Characteristics of the investigated women (x ± SEM)
Tabela I. Charakterystyka badanych kobiet (x ± SEM)
Parameter Investigated groups Statistical 
significance of 
differences (p)Control group (n = 26)
C
Hypothyroid patients (n = 24)
Before treatment
A
After attainment of 
euthyroid state, B
Body mass index [kg/m2] 26.2 ± 0.9 28.2 ± 0.5 26.9 ± 0.8 NS
Serum TSH level [mIU/l] 1.75 ± 0.29 38.42 ± 3.12 2.60 ± 0.41 A:C < 0.001
B:A < 0.001
Serum free T3 level [pmol/l] 5.68 ± 0.39 2.03 ± 0.21 5.53 ± 0.32 A:C < 0.001
B:A < 0.001
Serum free T4 level [pmol/l] 14.62 ± 0.89 5.08 ± 0.62 16.93 ± 1.27 A:C < 0.001
B:A < 0.001
Systolic blood pressure [mm Hg] 115.8 ± 2.6 125.6 ± 3.4 124.7 ± 2.9 A:C < 0.05
B:C < 0.05
Diastolic blood pressure [mm Hg] 78.6 ± 2.3 90.1 ± 2.1 85.3 ± 2.5 A:C < 0.001
Heart rate [beats/min] 78.5 ± 1.6 72.5 ± 1.6 76.9 ± 2.0 A:C < 0.05
NS — not significant 
Table II. Plasma arginine vasopressin (AVP), plasma osmolality and serum electrolytes levels in hypothyroid and healthy 
women (x ± SEM)
Tabela II. Stężenie argininowazopresyny (AVP) i osmolalność osocza oraz stężenie elektrolitów w surowicy kobiet 
z niedoczynnością tarczycy i zdrowych (x ± SEM)
Parameter Investigated groups Statistical 
significance of 
differences (p)Control group (n = 24), C
Hypothyroid patients (n = 26)
Before treatment, A After attainment of euthyroid state, B
Plasma AVP level 
[pg/ml]
I 2.60 ± 0.18 3.98 ± 0.39 2.61 ± 0.32 A:C < 0.001
B:A < 0.01
II 3.10 ± 0.21* 4.19 ± 0.36 3.43 ± 0.31** A:C < 0.01
B:A < 0.05
Plasma osmolality 
[mosm/kg H2O]
I 286.1 ± 0.9 282.1 ± 0.8 286.9 ± 1.1 A:C < 0.01
B:A < 0.001
II 286.4 ± 1.1 282.3 ± 1.1 287.3 ± 1.4 A:C < 0.01
B:A < 0.001
Serum sodium level 
[mmol/l]
I 139.0 ± 0.5 136.7 ± 0.4 139.2 ± 0.5 A:C < 0.01
B:A < 0.001
II 139.1 ± 0.5 136.4 ± 0.5 139.3 ± 0.6 A:C < 0.01
B:A < 0.001
Serum potassium 
level [mmol/l]
I 4.32 ± 0.06 4.47 ± 0.06 4.42 ± 0.05 NS
II 4.46 ± 0.05 4.58 ± 0.06 4.53 ± 0.07 NS
I — normal sodium diet; II — low sodium diet and upright position; in comparison with the values under basal conditions: *p < 0.05, **p < 0.01; 
NS — not significant
osmolality and natraemia in the untreated hypothyroid 
patients were lower than after treatment and in the 
C group, independently of the dietary sodium supply 
(Table II). The plasma level of AVP in hypothyroid women 
was negatively correlated with the serum free T3 concen-
tration (r = –0.44; p < 0.05). No correlation was found 
between vasopressinaemia and plasma osmolality.
Discussion
A literature survey shows that in hypothyroid patients 
and experimental animals with deficient thyroid hor-
mones, the plasma AVP level has proved to be ambigu-
ous, from increased through normal to decreased. The 
ambiguities in the results of these studies have not yet 
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been fully explained. On the basis of the presented 
investigations, the plasma AVP level measured under 
basal conditions and after the lsdp was higher in the 
hypothyroid women than in the healthy ones. The vaso-
pressinaemia increase measured under basal conditions 
has also been seen in other studies dealing with hypo-
thyroid patients [7–9] and experimental animals [3].
In the literature there are also casuistical descriptions 
of severe hypothyroidism, often with accompanying 
myxoedema coma and high AVP plasma level as well 
as decreased natraemia and osmolality, indicative of 
the Syndrome of Inappropriate AVP secretion (SIAVP) 
[12–14]. However, other studies have shown that in 
hypothyroidism, a vasopressinaemia increase has not 
been observed [10, 11] and it has even been seen to 
decrease [4–6]. The different directions of blood AVP 
level changes in hypothyroidism may indicate the con-
tribution of many factors to the complex mechanism of 
production, secretion and degradation of this hormone 
in the conditions of thyroid hormones deficiency. 
In hypothyroid patients, Laczi et al. [7] have shown 
a decrease of the plasma osmolality threshold condition-
ing the AVP secretion. Iwasaki et al. [5] have observed 
a substantially lower vasopressinaemia increase, as a result 
of the induced plasma hyperosmolality, than in patients 
with normal thyroid function. A similar reduction of the 
plasma AVP level increase after hypovolaemic stimula-
tion has been observed in experimental hypothyroidism 
in animals [4]. A similar mechanism regulating the AVP 
secretion into blood circulation may have also occurred 
in our own research, because the vasopressinaemia in the 
investigated hypothyroid women was increased in spite 
of the fact that the plasma osmolality was lower than the 
one shown in the patients with euthyreosis. In our study, 
it has been shown that in respect to the results obtained 
under basal conditions, no significant vasopressinaemia 
changes occurred as a result of the lsdp of short duration in 
the investigated hypothyroid women compared to the eu-
thyroid patients treated with L-thyroxine and healthy in-
dividuals showing an increased secretion of this hormone. 
Assuming that applying the low sodium diet leads to 
volaemia reduction, the AVP secretion stimulation should 
have been expected. The lack of hypothalamic-pituitary 
system response, involving the AVP secretion, to apply-
ing the lsdp in hypothyroid women may be connected 
to the disturbed sensitivity of this system to the volaemia 
changes. AVP secretion inhibition did not occur as a result 
of increased volaemia and reduced plasma osmolality un-
der conditions of thyroid hormones deficiency in people 
[15] or experimental animals [3]. In this investigation it 
was shown that a lack of significant correlation between 
plasma osmolality and vasopressinaemia in hypothyroid 
women may be indicative of the disturbed AVP secretion 
osmoregulation. Other investigators [11] have shown 
a similar lack of correlation between the plasma AVP level 
and its osmolality in hypothyroid patients. Moreover, they 
have not observed the neurohormone secretion inhibition 
as a result of the osmolality reduction induced in these 
patients with acute water load. Salomez-Granier et al. 
[16] have even shown a negative correlation between the 
plasma osmolality and vasopressinaemia in hypothyroid 
patients, which may contradict the physiological AVP 
secretion osmoregulation.
The normalisation of AVP concentration and its sig-
nificantly increased secretion occurred in euthyreosis as 
a result of the hormonal L-thyroxine substitution after 
applying the lsdp. It should be pointed out that in the 
studies of Ota et al. [11], the restoration of normal AVP 
secretion inhibition was observed in the treated hypo-
thyroid patients after an acute water load.
Conclusion
In hypothyroid women, the plasma arginine vasopressin 
level is increased and remains unaltered after the appli-
cation of a low sodium diet and in the upright position.
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